These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 27213693

  • 1. C5a induces caspase-dependent apoptosis in brain vascular endothelial cells in experimental lupus.
    Mahajan SD, Tutino VM, Redae Y, Meng H, Siddiqui A, Woodruff TM, Jarvis JN, Hennon T, Schwartz S, Quigg RJ, Alexander JJ.
    Immunology; 2016 Aug; 148(4):407-19. PubMed ID: 27213693
    [Abstract] [Full Text] [Related]

  • 2. C5a alters blood-brain barrier integrity in experimental lupus.
    Jacob A, Hack B, Chiang E, Garcia JG, Quigg RJ, Alexander JJ.
    FASEB J; 2010 Jun; 24(6):1682-8. PubMed ID: 20065106
    [Abstract] [Full Text] [Related]

  • 3. C5a alters blood-brain barrier integrity in a human in vitro model of systemic lupus erythematosus.
    Mahajan SD, Parikh NU, Woodruff TM, Jarvis JN, Lopez M, Hennon T, Cunningham P, Quigg RJ, Schwartz SA, Alexander JJ.
    Immunology; 2015 Sep; 146(1):130-43. PubMed ID: 26059553
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of C5a receptor alleviates experimental CNS lupus.
    Jacob A, Hack B, Bai T, Brorson JR, Quigg RJ, Alexander JJ.
    J Neuroimmunol; 2010 Apr 15; 221(1-2):46-52. PubMed ID: 20207017
    [Abstract] [Full Text] [Related]

  • 5. Absence of functional alternative complement pathway alleviates lupus cerebritis.
    Alexander JJ, Jacob A, Vezina P, Sekine H, Gilkeson GS, Quigg RJ.
    Eur J Immunol; 2007 Jun 15; 37(6):1691-701. PubMed ID: 17523212
    [Abstract] [Full Text] [Related]

  • 6. C5a promotes development of experimental lupus nephritis which can be blocked with a specific receptor antagonist.
    Bao L, Osawe I, Puri T, Lambris JD, Haas M, Quigg RJ.
    Eur J Immunol; 2005 Aug 15; 35(8):2496-506. PubMed ID: 16052609
    [Abstract] [Full Text] [Related]

  • 7. Transcriptional profiling reveals that C5a alters microRNA in brain endothelial cells.
    Eadon MT, Jacob A, Cunningham PN, Quigg RJ, Garcia JG, Alexander JJ.
    Immunology; 2014 Nov 15; 143(3):363-73. PubMed ID: 24801999
    [Abstract] [Full Text] [Related]

  • 8. C5a Increases the Injury to Primary Neurons Elicited by Fibrillar Amyloid Beta.
    Hernandez MX, Namiranian P, Nguyen E, Fonseca MI, Tenner AJ.
    ASN Neuro; 2017 Feb 15; 9(1):1759091416687871. PubMed ID: 28078911
    [Abstract] [Full Text] [Related]

  • 9. In response to complement anaphylatoxin peptides C3a and C5a, human vascular endothelial cells migrate and mediate the activation of B-cells and polarization of T-cells.
    Shivshankar P, Li YD, Mueller-Ortiz SL, Wetsel RA.
    FASEB J; 2020 Jun 15; 34(6):7540-7560. PubMed ID: 32301538
    [Abstract] [Full Text] [Related]

  • 10. TNF-like weak inducer of apoptosis promotes blood brain barrier disruption and increases neuronal cell death in MRL/lpr mice.
    Wen J, Doerner J, Weidenheim K, Xia Y, Stock A, Michaelson JS, Baruch K, Deczkowska A, Gulinello M, Schwartz M, Burkly LC, Putterman C.
    J Autoimmun; 2015 Jun 15; 60():40-50. PubMed ID: 25911200
    [Abstract] [Full Text] [Related]

  • 11. The critical role of C5a as an initiator of neutrophil-mediated autoimmune inflammation of the joint and skin.
    Sadik CD, Miyabe Y, Sezin T, Luster AD.
    Semin Immunol; 2018 Jun 15; 37():21-29. PubMed ID: 29602515
    [Abstract] [Full Text] [Related]

  • 12. Complement anaphylatoxin C5a neuroprotects through mitogen-activated protein kinase-dependent inhibition of caspase 3.
    Mukherjee P, Pasinetti GM.
    J Neurochem; 2001 Apr 15; 77(1):43-9. PubMed ID: 11279260
    [Abstract] [Full Text] [Related]

  • 13. C5a/CD88 signaling alters blood-brain barrier integrity in lupus through nuclear factor-κB.
    Jacob A, Hack B, Chen P, Quigg RJ, Alexander JJ.
    J Neurochem; 2011 Dec 15; 119(5):1041-51. PubMed ID: 21929539
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological characterisation of small molecule C5aR1 inhibitors in human cells reveals biased activities for signalling and function.
    Li XX, Lee JD, Massey NL, Guan C, Robertson AAB, Clark RJ, Woodruff TM.
    Biochem Pharmacol; 2020 Oct 15; 180():114156. PubMed ID: 32682759
    [Abstract] [Full Text] [Related]

  • 15. Neuropsychiatric Systemic Lupus Erythematosus Is Dependent on Sphingosine-1-Phosphate Signaling.
    Mike EV, Makinde HM, Der E, Stock A, Gulinello M, Gadhvi GT, Winter DR, Cuda CM, Putterman C.
    Front Immunol; 2018 Oct 15; 9():2189. PubMed ID: 30319641
    [Abstract] [Full Text] [Related]

  • 16. Administration of the soluble complement inhibitor, Crry-Ig, reduces inflammation and aquaporin 4 expression in lupus cerebritis.
    Alexander JJ, Bao L, Jacob A, Kraus DM, Holers VM, Quigg RJ.
    Biochim Biophys Acta; 2003 Nov 20; 1639(3):169-76. PubMed ID: 14636948
    [Abstract] [Full Text] [Related]

  • 17. Activation of the endoplasmic reticulum stress response by the amyloid-beta 1-40 peptide in brain endothelial cells.
    Fonseca AC, Ferreiro E, Oliveira CR, Cardoso SM, Pereira CF.
    Biochim Biophys Acta; 2013 Dec 20; 1832(12):2191-203. PubMed ID: 23994613
    [Abstract] [Full Text] [Related]

  • 18. Dysregulated complement activation during acute myocardial infarction leads to endothelial glycocalyx degradation and endothelial dysfunction via the C5a:C5a-Receptor1 axis.
    Vahldieck C, Löning S, Hamacher C, Fels B, Rudzewski B, Nickel L, Weil J, Nording H, Baron L, Kleingarn M, Karsten CM, Kusche-Vihrog K.
    Front Immunol; 2024 Dec 20; 15():1426526. PubMed ID: 39055717
    [Abstract] [Full Text] [Related]

  • 19. Complement C5a induces mesenchymal stem cell apoptosis during the progression of chronic diabetic complications.
    Zhu M, He X, Wang XH, Qiu W, Xing W, Guo W, An TC, Ao LQ, Hu XT, Li Z, Liu XP, Xiao N, Yu J, Huang H, Xu X.
    Diabetologia; 2017 Sep 20; 60(9):1822-1833. PubMed ID: 28577176
    [Abstract] [Full Text] [Related]

  • 20. High Concentration of C5a-Induced Mitochondria-Dependent Apoptosis in Murine Kidney Endothelial Cells.
    Tsai IJ, Lin WC, Yang YH, Tseng YL, Lin YH, Chou CH, Tsau YK.
    Int J Mol Sci; 2019 Sep 10; 20(18):. PubMed ID: 31510052
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.